FDA Grants Approval to Zongertinib for Advanced Lung Cancer
The U.S. Food and Drug Administration approved zongertinib for adults with unresectable or metastatic non-squamous non-small cell lung cancer. This decision expands targeted treatment options for patients whose tumors carry specific HER2 ty..
